Our meta-analysis indicates that while supplementation with DHEA and CoQ10 did not significantly improve live birth or clinical pregnancy rates in unselected DOR/POR patients, these supplements may still hold clinical value for specific patient subgroups
Heres our full answer
Protocol 3: Comprehensive approach (advanced, with medical supervision) Goal: Full-spectrum immune modulation with organ support Phase 1 (Weeks 1-4): Foundation Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly BPC-157: 300 mcg subcutaneously, twice daily Phase 2 (Weeks 5-12): Add modulation Continue Phase 1 peptides Add KPV: 300-500 mcg subcutaneously, once daily Add Selank: 500 mcg intranasally, once daily Phase 3 (Weeks 13-16): Organ support cycle Continue Phase 2 peptides Add Thymalin: 10 mg course over 10 days Add targeted bioregulators based on affected organs (kidney, cardiac, vascular as needed) Phase 4 (Weeks 17-20): Rest and assess Discontinue all peptides Monitor disease activity markers Assess sustained benefits Plan next cycle based on results Monitoring: Full labs every 4 weeks, including CBC, CMP, complement levels, anti-dsDNA, CRP, ESR, urine protein/creatinine ratio
[DOI] [PubMed] [Google Scholar] 99.Kassebaum N.J., Fleming T.D., Flaxman A., Phillips D.E., Steiner C., Barber R.M., Hanson S.W., Moradi-Lakeh M., Coffeng L.E., Haagsma J., et al
